Ocular Trauma Caused by Confetti Cannons

Isr Med Assoc J. 2021 Nov;23(11):703-707.

Abstract

Background: Eye trauma is an unfortunate and often preventable cause of vision loss. Confetti cannons are common causes of injury. Awareness of ocular hazards of confetti cannons remains low because of limited reports describing ophthalmic injuries following their use.

Objectives: To describe outcomes of ocular trauma caused by confetti cannons and to increase recognition of their ocular risks.

Methods: A retrospective analysis was conducted of eye injuries caused by confetti cannons presenting to a single medical center between 2016 and 2020. Data collected included age, gender, eye injured, ocular damage, visual outcome, and details of surgeries performed.

Results: Overall, six consecutive patients (2 males, mean age 19.5 ± 9.74 years) were identified and studied. In all patients only one eye was injured (3 right eyes) during a private celebration, most commonly (n=5) to a bystander while in the vicinity of a cannon operated by someone else. Most common eye injuries included corneal erosion (n=4), traumatic hyphema (n=4), and retinal edema (n=3). Mean initial logMAR visual acuity in the injured eye was 0.73 ± 0.18, improving to 0.25 ± 0.16 at the final visit (P = 0.125). Two patients underwent eye surgery due to their trauma: one to repair globe penetration and another to undergo intravitreal injection of tissue plasminogen activator and C3F8 for submacular hemorrhage, followed 8 months later by intravitreal bevacizumab injection for choroidal neovascularization.

Conclusions: Confetti cannons pose hazards that can cause severe ocular trauma resulting in permanent vision loss. Increasing awareness of device hazards is necessary to prevent eye injuries.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Angiogenesis Inhibitors / administration & dosage
  • Bevacizumab / administration & dosage*
  • Child
  • Choroidal Neovascularization / prevention & control
  • Corneal Injuries* / diagnosis
  • Corneal Injuries* / etiology
  • Corneal Injuries* / therapy
  • Eye Injuries* / etiology
  • Eye Injuries* / pathology
  • Eye Injuries* / physiopathology
  • Eye Injuries* / therapy
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Hyphema* / diagnosis
  • Hyphema* / etiology
  • Hyphema* / therapy
  • Intravitreal Injections / methods
  • Male
  • Papilledema* / diagnosis
  • Papilledema* / etiology
  • Papilledema* / therapy
  • Retrospective Studies
  • Tissue Plasminogen Activator / therapeutic use*
  • Trauma Severity Indices
  • Vision Tests / methods
  • Visual Acuity

Substances

  • Angiogenesis Inhibitors
  • Fibrinolytic Agents
  • Bevacizumab
  • Tissue Plasminogen Activator